Dr. Nigel Mouncey
DOE Joint Genome Institute
“New Voyages to Explore the Natural Product Galaxy”
About Dr. Nigel Mouncey
Dr. Mouncey joined the DOE Joint Genome Institute in 2017 as the fourth Director in its 20-year history. After stints as a senior research scientist in molecular biology at Roche Vitamins, Inc. in New Jersey and DSM Nutritional Products in Switzerland, he joined Dow AgroSciences in Indianapolis in 2008 and served as Bioengineering and Bioprocessing R&D Director and Leader from 2011 onward. There, Mouncey directed a 70-member R&D team that supported the growth of a highly successful natural product insecticide that has since generated hundreds of millions of dollars of revenue and significant societal benefit, through isolating, optimizing, and scaling-up of new production strains for commercial manufacturing by fermentation. He also built an integrated and highly effective bioprocessing team comprising high-throughput screening, metabolic engineering, engineering biology, systems biology, enzymology, protein expression, fermentation and analytical capabilities. His team also developed production strains and fermentation processes for other molecules such as a new fungicide, propionic acid and long-chain alcohols, as well as supporting the discovery of new crop traits.
He received his BSc (Honours) in Microbiology from The University of Glasgow and Ph.D. in Biochemistry from the University of Sussex with Postdoctoral training at Harvard Medical School and the University of Texas Medical School in Houston.
Awards and Honors
- 2016 World Bio Markets Bio-based Business Person of the Year
- 13 granted patents, 33 pending
- Diversity Committee Member, Society for Industrial Microbiology and Biotechnology
- Publications Committee Chair, Society for Industrial Microbiology and Biotechnology